Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use
Glioblastomas (GBMs) are high-grade malignancies with a poor prognosis. The current standard of care for GBM is maximal surgical resection followed by radiotherapy and chemotherapy. Despite all these treatments, the overall survival is still limited, with a median of 15 months. For patients harborin...
Guardado en:
Autores principales: | Henri-Arthur Leroy, Gregory Baert, Laura Guerin, Nadira Delhem, Serge Mordon, Nicolas Reyns, Anne-Sophie Vignion-Dewalle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b11426700b94ed1964bb3d122a2aa1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autophagy and Apoptosis Induced in U87 MG Glioblastoma Cells by Hypericin-Mediated Photodynamic Therapy Can Be Photobiomodulated with 808 nm Light
por: Viktoria Pevna, et al.
Publicado: (2021) -
Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries M, et al.
Publicado: (2020) -
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas E, et al.
Publicado: (2017) -
Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy
por: Jianfeng Hua, et al.
Publicado: (2021) -
Current Status of Photodynamic Diagnosis for Gastric Tumors
por: Hiroki Kurumi, et al.
Publicado: (2021)